EMEA (Europe, Middle East and Africa) Cell Therapy Market Report 2017

October 2017 | 129 pages | ID: EB8B20962D5WEN
QYResearch

Abstracts

In this report, the EMEA Cell Therapy market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K Units), revenue (Million USD), market share and growth rate of Cell Therapy for these regions, from 2012 to 2022 (forecast)

• Europe: Germany, France, UK, Russia, Italy and Benelux;
• Middle East: Saudi Arabia, Israel, UAE and Iran;
• Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Cell Therapy market competition by top manufacturers/players, with Cell Therapy sales volume (K Units), price (USD/Unit), revenue (Million USD) and market share for each manufacturer/player; the top players including

• Dendreon
• Mesoblast
• Vericel
• AlloCure
• Amorcyte
• Anterogen
• Antibe Therapeutics
• Astellas Pharma
• Athersys
• Avita Medical
• AxoGen
• Bellicum Pharmaceuticals
• BioCardia
• BIOCELLULAR THERAPIES
• Biogen Idec
• Bio-Tissue
• BIOTIME
• BioTissue Technologies
• BrainStorm Cell Therapeutics
• Bluebird Bio
• Bone Therapeutics
• Caladrius
• Capricor Therapeutics
• CellBioMed
• Celgene
• Cell Medica

On the basis of product, this report displays the sales volume (K Units), revenue (Million USD), product price (USD/Unit), market share and growth rate of each type, primarily split into

• Nanotechnology
• Natural Substances

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K Units), market share and growth rate of Cell Therapy for each application, including

• Scientific Research
• Hospital
• Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

EMEA (Europe, Middle East and Africa) Cell Therapy Market Report 2017

1 CELL THERAPY OVERVIEW

1.1 Product Overview and Scope of Cell Therapy
1.2 Classification of Cell Therapy
  1.2.1 EMEA Cell Therapy Market Size (Sales) Comparison by Type (2012-2022)
  1.2.2 EMEA Cell Therapy Market Size (Sales) Market Share by Type (Product Category) in 2016
  1.2.3 Nanotechnology
  1.2.4 Natural Substances
1.3 EMEA Cell Therapy Market by Application/End Users
  1.3.1 EMEA Cell Therapy Sales (Volume) and Market Share Comparison by Application (2012-2022
  1.3.2 Scientific Research
  1.3.3 Hospital
  1.3.4 Other
1.4 EMEA Cell Therapy Market by Region
  1.4.1 EMEA Cell Therapy Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 Europe Status and Prospect (2012-2022)
  1.4.3 Middle East Status and Prospect (2012-2022)
  1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Cell Therapy (2012-2022)
  1.5.1 EMEA Cell Therapy Sales and Growth Rate (2012-2022)
  1.5.2 EMEA Cell Therapy Revenue and Growth Rate (2012-2022)

2 EMEA CELL THERAPY COMPETITION BY MANUFACTURERS/PLAYERS/SUPPLIERS, REGION, TYPE AND APPLICATION

2.1 EMEA Cell Therapy Market Competition by Players/Manufacturers
  2.1.1 EMEA Cell Therapy Sales Volume and Market Share of Major Players (2012-2017)
  2.1.2 EMEA Cell Therapy Revenue and Share by Players (2012-2017)
  2.1.3 EMEA Cell Therapy Sale Price by Players (2012-2017)
2.2 EMEA Cell Therapy (Volume and Value) by Type/Product Category
  2.2.1 EMEA Cell Therapy Sales and Market Share by Type (2012-2017)
  2.2.2 EMEA Cell Therapy Revenue and Market Share by Type (2012-2017)
  2.2.3 EMEA Cell Therapy Sale Price by Type (2012-2017)
2.3 EMEA Cell Therapy (Volume) by Application
2.4 EMEA Cell Therapy (Volume and Value) by Region
  2.4.1 EMEA Cell Therapy Sales and Market Share by Region (2012-2017)
  2.4.2 EMEA Cell Therapy Revenue and Market Share by Region (2012-2017)
  2.4.3 EMEA Cell Therapy Sales Price by Region (2012-2017)

3 EUROPE CELL THERAPY (VOLUME, VALUE AND SALES PRICE), BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

3.1 Europe Cell Therapy Sales and Value (2012-2017)
  3.1.1 Europe Cell Therapy Sales Volume and Growth Rate (2012-2017)
  3.1.2 Europe Cell Therapy Revenue and Growth Rate (2012-2017)
3.2 Europe Cell Therapy Sales and Market Share by Type
3.3 Europe Cell Therapy Sales and Market Share by Application
3.4 Europe Cell Therapy Sales Volume and Value (Revenue) by Countries
  3.4.1 Europe Cell Therapy Sales Volume by Countries (2012-2017)
  3.4.2 Europe Cell Therapy Revenue by Countries (2012-2017)
  3.4.3 Germany Cell Therapy Sales and Growth Rate (2012-2017)
  3.4.4 France Cell Therapy Sales and Growth Rate (2012-2017)
  3.4.5 UK Cell Therapy Sales and Growth Rate (2012-2017)
  3.4.6 Russia Cell Therapy Sales and Growth Rate (2012-2017)
  3.4.7 Italy Cell Therapy Sales and Growth Rate (2012-2017)
  3.4.8 Benelux Cell Therapy Sales and Growth Rate (2012-2017)

4 MIDDLE EAST CELL THERAPY (VOLUME, VALUE AND SALES PRICE), BY REGION, TYPE AND APPLICATION

4.1 Middle East Cell Therapy Sales and Value (2012-2017)
  4.1.1 Middle East Cell Therapy Sales Volume and Growth Rate (2012-2017)
  4.1.2 Middle East Cell Therapy Revenue and Growth Rate (2012-2017)
4.2 Middle East Cell Therapy Sales and Market Share by Type
4.3 Middle East Cell Therapy Sales and Market Share by Application
4.4 Middle East Cell Therapy Sales Volume and Value (Revenue) by Countries
  4.4.1 Middle East Cell Therapy Sales Volume by Countries (2012-2017)
  4.4.2 Middle East Cell Therapy Revenue by Countries (2012-2017)
  4.4.3 Saudi Arabia Cell Therapy Sales and Growth Rate (2012-2017)
  4.4.4 Israel Cell Therapy Sales and Growth Rate (2012-2017)
  4.4.5 UAE Cell Therapy Sales and Growth Rate (2012-2017)
  4.4.6 Iran Cell Therapy Sales and Growth Rate (2012-2017)

5 AFRICA CELL THERAPY (VOLUME, VALUE AND SALES PRICE) BY PLAYERS, COUNTRIES, TYPE AND APPLICATION

5.1 Africa Cell Therapy Sales and Value (2012-2017)
  5.1.1 Africa Cell Therapy Sales Volume and Growth Rate (2012-2017)
  5.1.2 Africa Cell Therapy Revenue and Growth Rate (2012-2017)
5.2 Africa Cell Therapy Sales and Market Share by Type
5.3 Africa Cell Therapy Sales and Market Share by Application
5.4 Africa Cell Therapy Sales Volume and Value (Revenue) by Countries
  5.4.1 Africa Cell Therapy Sales Volume by Countries (2012-2017)
  5.4.2 Africa Cell Therapy Revenue by Countries (2012-2017)
  5.4.3 South Africa Cell Therapy Sales and Growth Rate (2012-2017)
  5.4.4 Nigeria Cell Therapy Sales and Growth Rate (2012-2017)
  5.4.5 Egypt Cell Therapy Sales and Growth Rate (2012-2017)
  5.4.6 Algeria Cell Therapy Sales and Growth Rate (2012-2017)

6 EMEA CELL THERAPY MANUFACTURERS/PLAYERS PROFILES AND SALES DATA

6.1 Dendreon
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cell Therapy Product Type, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Dendreon Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Mesoblast
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Cell Therapy Product Type, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Mesoblast Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Vericel
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Cell Therapy Product Type, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Vericel Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 AlloCure
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Cell Therapy Product Type, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 AlloCure Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Amorcyte
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Cell Therapy Product Type, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Amorcyte Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Anterogen
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Cell Therapy Product Type, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Anterogen Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Antibe Therapeutics
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Cell Therapy Product Type, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Antibe Therapeutics Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Astellas Pharma
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Cell Therapy Product Type, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Astellas Pharma Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Athersys
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Cell Therapy Product Type, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Athersys Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview
6.10 Avita Medical
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Cell Therapy Product Type, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Avita Medical Cell Therapy Sales, Revenue, Price and Gross Margin (2012-2017)
  6.10.4 Main Business/Business Overview
6.11 AxoGen
6.12 Bellicum Pharmaceuticals
6.13 BioCardia
6.14 BIOCELLULAR THERAPIES
6.15 Biogen Idec
6.16 Bio-Tissue
6.17 BIOTIME
6.18 BioTissue Technologies
6.19 BrainStorm Cell Therapeutics
6.20 Bluebird Bio
6.21 Bone Therapeutics
6.22 Caladrius
6.23 Capricor Therapeutics
6.24 CellBioMed
6.25 Celgene
6.26 Cell Medica

7 CELL THERAPY MANUFACTURING COST ANALYSIS

7.1 Cell Therapy Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cell Therapy

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cell Therapy Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cell Therapy Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA CELL THERAPY MARKET FORECAST (2017-2022)

11.1 EMEA Cell Therapy Sales, Revenue and Price Forecast (2017-2022)
  11.1.1 EMEA Cell Therapy Sales and Growth Rate Forecast (2017-2022)
  11.1.2 EMEA Cell Therapy Revenue and Growth Rate Forecast (2017-2022)
  11.1.3 EMEA Cell Therapy Price and Trend Forecast (2017-2022)
11.2 EMEA Cell Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Cell Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Cell Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Cell Therapy Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Cell Therapy Sales Forecast by Type (2017-2022)
11.7 EMEA Cell Therapy Sales Forecast by Application (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cell Therapy
Figure EMEA Cell Therapy Sales Volume (K Units) by Type (2012-2022)
Figure EMEA Cell Therapy Sales Volume Market Share by Type (Product Category) in 2016
Figure Nanotechnology Product Picture
Figure Natural Substances Product Picture
Figure EMEA Cell Therapy Sales Volume (K Units) by Application (2012-2022)
Figure EMEA Sales Market Share of Cell Therapy by Application in 2016
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Other Examples
Table Key Downstream Customer in Other
Figure EMEA Cell Therapy Market Size (Million USD) by Region (2012-2022)
Figure Europe Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Cell Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Cell Therapy Revenue (Million USD) Status and Forecast by Countries
Figure Africa Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Cell Therapy Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Cell Therapy Sales Volume and Growth Rate (2012-2022)
Figure EMEA Cell Therapy Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Cell Therapy Market Major Players Product Sales Volume (K Units) (2012-2017)
Table EMEA Cell Therapy Sales Volume (K Units) of Major Players (2012-2017)
Table EMEA Cell Therapy Sales Share by Players (2012-2017)
Figure 2016 Cell Therapy Sales Share by Players
Figure 2017 Cell Therapy Sales Share by Players
Figure EMEA Cell Therapy Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Cell Therapy Revenue (Million USD) by Players (2012-2017)
Table EMEA Cell Therapy Revenue Share by Players (2012-2017)
Table 2016 EMEA Cell Therapy Revenue Share by Players
Table 2017 EMEA Cell Therapy Revenue Share by Players
Table EMEA Cell Therapy Sale Price (USD/Unit) by Players (2012-2017)
Table EMEA Cell Therapy Sales (K Units) and Market Share by Type (2012-2017)
Table EMEA Cell Therapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Cell Therapy by Type (2012-2017)
Figure EMEA Cell Therapy Sales Market Share by Type (2012-2017)
Table EMEA Cell Therapy Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Cell Therapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cell Therapy by Type in 2016
Table EMEA Cell Therapy Sale Price (USD/Unit) by Type (2012-2017)
Table EMEA Cell Therapy Sales (K Units) and Market Share by Application (2012-2017)
Table EMEA Cell Therapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Cell Therapy by Application (2012-2017)
Figure EMEA Cell Therapy Sales Market Share by Application in 2016
Table EMEA Cell Therapy Sales (K Units) and Market Share by Region (2012-2017)
Table EMEA Cell Therapy Sales Share by Region (2012-2017)
Figure Sales Market Share of Cell Therapy by Region (2012-2017)
Figure EMEA Cell Therapy Sales Market Share in 2016
Table EMEA Cell Therapy Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Cell Therapy Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Cell Therapy by Region (2012-2017)
Figure EMEA Cell Therapy Revenue Market Share Regions in 2016
Table EMEA Cell Therapy Sales Price (USD/Unit) by Region (2012-2017)
Figure Europe Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Europe Cell Therapy Revenue and Growth Rate (2012-2017)
Table Europe Cell Therapy Sales (K Units) by Type (2012-2017)
Table Europe Cell Therapy Market Share by Type (2012-2017)
Figure Europe Cell Therapy Market Share by Type in 2016
Table Europe Cell Therapy Sales (K Units) by Application (2012-2017)
Table Europe Cell Therapy Market Share by Application (2012-2017)
Figure Europe Cell Therapy Market Share by Application in 2016
Table Europe Cell Therapy Sales (K Units) by Countries (2012-2017)
Table Europe Cell Therapy Sales Market Share by Countries (2012-2017)
Figure Europe Cell Therapy Sales Market Share by Countries (2012-2017)
Figure Europe Cell Therapy Sales Market Share by Countries in 2016
Table Europe Cell Therapy Revenue (Million USD) by Countries (2012-2017)
Table Europe Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Europe Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Europe Cell Therapy Revenue Market Share by Countries in 2016
Figure Germany Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure France Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure UK Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Russia Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Italy Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Benelux Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Middle East Cell Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Cell Therapy Sales (K Units) by Type (2012-2017)
Table Middle East Cell Therapy Market Share by Type (2012-2017)
Figure Middle East Cell Therapy Market Share by Type (2012-2017)
Table Middle East Cell Therapy Sales (K Units) by Applications (2012-2017)
Table Middle East Cell Therapy Market Share by Applications (2012-2017)
Figure Middle East Cell Therapy Sales Market Share by Application in 2016
Table Middle East Cell Therapy Sales Volume (K Units) by Countries (2012-2017)
Table Middle East Cell Therapy Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Cell Therapy Sales Volume Market Share by Countries in 2016
Table Middle East Cell Therapy Revenue (Million USD) by Countries (2012-2017)
Table Middle East Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Middle East Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Middle East Cell Therapy Revenue Market Share by Countries in 2016
Figure Saudi Arabia Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Israel Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure UAE Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Iran Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Africa Cell Therapy Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Cell Therapy Sales (K Units) by Type (2012-2017)
Table Africa Cell Therapy Sales Market Share by Type (2012-2017)
Figure Africa Cell Therapy Sales Market Share by Type (2012-2017)
Figure Africa Cell Therapy Sales Market Share by Type in 2016
Table Africa Cell Therapy Sales (K Units) by Application (2012-2017)
Table Africa Cell Therapy Sales Market Share by Application (2012-2017)
Figure Africa Cell Therapy Sales Market Share by Application (2012-2017)
Table Africa Cell Therapy Sales Volume (K Units) by Countries (2012-2017)
Table Africa Cell Therapy Sales Market Share by Countries (2012-2017)
Figure Africa Cell Therapy Sales Market Share by Countries (2012-2017)
Figure Africa Cell Therapy Sales Market Share by Countries in 2016
Table Africa Cell Therapy Revenue (Million USD) by Countries (2012-2017)
Table Africa Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Africa Cell Therapy Revenue Market Share by Countries (2012-2017)
Figure Africa Cell Therapy Revenue Market Share by Countries in 2016
Figure South Africa Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Nigeria Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Egypt Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Algeria Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Table Dendreon Cell Therapy Basic Information List
Table Dendreon Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Dendreon Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Dendreon Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Dendreon Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Mesoblast Cell Therapy Basic Information List
Table Mesoblast Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Mesoblast Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Mesoblast Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Mesoblast Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Vericel Cell Therapy Basic Information List
Table Vericel Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Vericel Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Vericel Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Vericel Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table AlloCure Cell Therapy Basic Information List
Table AlloCure Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure AlloCure Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure AlloCure Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure AlloCure Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Amorcyte Cell Therapy Basic Information List
Table Amorcyte Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Amorcyte Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Amorcyte Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Amorcyte Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Anterogen Cell Therapy Basic Information List
Table Anterogen Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Anterogen Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Anterogen Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Anterogen Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Antibe Therapeutics Cell Therapy Basic Information List
Table Antibe Therapeutics Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Antibe Therapeutics Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Antibe Therapeutics Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Antibe Therapeutics Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Astellas Pharma Cell Therapy Basic Information List
Table Astellas Pharma Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Astellas Pharma Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Astellas Pharma Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Astellas Pharma Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Athersys Cell Therapy Basic Information List
Table Athersys Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Athersys Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Athersys Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Athersys Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table Avita Medical Cell Therapy Basic Information List
Table Avita Medical Cell Therapy Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)
Figure Avita Medical Cell Therapy Sales (K Units) and Growth Rate (2012-2017)
Figure Avita Medical Cell Therapy Sales Market Share in EMEA (2012-2017)
Figure Avita Medical Cell Therapy Revenue Market Share in EMEA (2012-2017)
Table AxoGen Cell Therapy Basic Information List
Table Bellicum Pharmaceuticals Cell Therapy Basic Information List
Table BioCardia Cell Therapy Basic Information List
Table BIOCELLULAR THERAPIES Cell Therapy Basic Information List
Table Biogen Idec Cell Therapy Basic Information List
Table Bio-Tissue Cell Therapy Basic Information List
Table BIOTIME Cell Therapy Basic Information List
Table BioTissue Technologies Cell Therapy Basic Information List
Table BrainStorm Cell Therapeutics Cell Therapy Basic Information List
Table Bluebird Bio Cell Therapy Basic Information List
Table Bone Therapeutics Cell Therapy Basic Information List
Table Caladrius Cell Therapy Basic Information List
Table Capricor Therapeutics Cell Therapy Basic Information List
Table CellBioMed Cell Therapy Basic Information List
Table Celgene Cell Therapy Basic Information List
Table Cell Medica Cell Therapy Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cell Therapy
Figure Manufacturing Process Analysis of Cell Therapy
Figure Cell Therapy Industrial Chain Analysis
Table Raw Materials Sources of Cell Therapy Major Manufacturers in 2016
Table Major Buyers of Cell Therapy
Table Distributors/Traders List
Figure EMEA Cell Therapy Sales (K Units) and Growth Rate Forecast (2017-2022)
Figure EMEA Cell Therapy Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Cell Therapy Price (USD/Unit) and Trend Forecast (2017-2022)
Table EMEA Cell Therapy Sales (K Units) Forecast by Region (2017-2022)
Figure EMEA Cell Therapy Sales Market Share Forecast by Region (2017-2022)
Table EMEA Cell Therapy Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Cell Therapy Revenue Market Share Forecast by Region (2017-2022)
Table Europe Cell Therapy Sales (K Units) Forecast by Countries (2017-2022)
Figure Europe Cell Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Europe Cell Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Cell Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Cell Therapy Sales (K Units) Forecast by Countries (2017-2022)
Figure Middle East Cell Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Cell Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Cell Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Cell Therapy Sales (K Units) Forecast by Countries (2017-2022)
Figure Africa Cell Therapy Sales Market Share Forecast by Countries (2017-2022)
Table Africa Cell Therapy Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Cell Therapy Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Cell Therapy Sales (K Units) Forecast by Type (2017-2022)
Figure EMEA Cell Therapy Sales Market Share Forecast by Type (2017-2022)
Table EMEA Cell Therapy Sales (K Units) Forecast by Application (2017-2022)
Figure EMEA Cell Therapy Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources